{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:06:16Z","timestamp":1786982776613,"version":"build-2736575974"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s40266-020-00777-8","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T23:57:31Z","timestamp":1592524651000},"page":"559-565","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Overactive Bladder in Frail Older Adults"],"prefix":"10.1007","volume":"37","author":[{"given":"Christina","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5372-530X","authenticated-orcid":false,"given":"Adrian","family":"Wagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"issue":"2","key":"777_CR1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/nau.23897","volume":"38","author":"C D\u2019Ancona","year":"2019","unstructured":"D\u2019Ancona C, et al. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn. 2019;38(2):433\u201377.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"777_CR2","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306\u201314 discussion 1314\u20135.","journal-title":"Eur Urol"},{"issue":"4","key":"777_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00404-007-0505-3","volume":"277","author":"MA Farage","year":"2008","unstructured":"Farage MA, et al. Psychosocial and societal burden of incontinence in the aged population: a review. Arch Gynecol Obstet. 2008;277(4):285\u201390.","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"777_CR4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","volume":"20","author":"WF Stewart","year":"2003","unstructured":"Stewart WF, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327\u201336.","journal-title":"World J Urol"},{"issue":"4","key":"777_CR5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1524-4733.2004.74008.x","volume":"7","author":"KS Coyne","year":"2004","unstructured":"Coyne KS, et al. The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health. 2004;7(4):455\u201363.","journal-title":"Value Health"},{"issue":"6","key":"777_CR6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1532-5415.1998.tb03802.x","volume":"46","author":"TM Johnson 2nd","year":"1998","unstructured":"Johnson TM 2nd, et al. The association of urinary incontinence with poor self-rated health. J Am Geriatr Soc. 1998;46(6):693\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"777_CR7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1532-5415.2000.tb04699.x","volume":"48","author":"E Dugan","year":"2000","unstructured":"Dugan E, et al. The association of depressive symptoms and urinary incontinence among older adults. J Am Geriatr Soc. 2000;48(4):413\u20136.","journal-title":"J Am Geriatr Soc"},{"key":"777_CR8","doi-asserted-by":"crossref","unstructured":"Calado, L.B., et al., Frailty syndrome in an independent urban population in Brazil (FIBRA study): a cross-sectional populational study. Sao Paulo Med J. 2016.","DOI":"10.1590\/1516-3180.2016.0078180516"},{"issue":"2","key":"777_CR9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0004-9514(09)70038-8","volume":"55","author":"PE Chiarelli","year":"2009","unstructured":"Chiarelli PE, Mackenzie LA, Osmotherly PG. Urinary incontinence is associated with an increase in falls: a systematic review. Aust J Physiother. 2009;55(2):89\u201395.","journal-title":"Aust J Physiother"},{"issue":"3","key":"777_CR10","first-page":"398","volume":"98","author":"L Wilson","year":"2001","unstructured":"Wilson L, et al. Annual direct cost of urinary incontinence. Obstet Gynecol. 2001;98(3):398\u2013406.","journal-title":"Obstet Gynecol"},{"issue":"8","key":"777_CR11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/gerona\/58.8.M756","volume":"58","author":"M Nuotio","year":"2003","unstructured":"Nuotio M, et al. Predictors of institutionalization in an older population during a 13-year period: the effect of urge incontinence. J Gerontol A Biol Sci Med Sci. 2003;58(8):756\u201362.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"777_CR12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF03324470","volume":"14","author":"M Nuotio","year":"2002","unstructured":"Nuotio M, et al. Urgency and urge incontinence in an older population: ten-year changes and their association with mortality. Aging Clin Exp Res. 2002;14(5):412\u20139.","journal-title":"Aging Clin Exp Res"},{"issue":"9","key":"777_CR13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s40266-018-0577-8","volume":"35","author":"A Wagg","year":"2018","unstructured":"Wagg A. Anticholinergics for overactive bladder in frail and medically complex older people: the case for. Drugs Aging. 2018;35(9):777\u201380.","journal-title":"Drugs Aging"},{"issue":"17","key":"777_CR14","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/jama.1995.03520410042024","volume":"273","author":"ME Tinetti","year":"1995","unstructured":"Tinetti ME, et al. Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA. 1995;273(17):1348\u201353.","journal-title":"JAMA"},{"key":"777_CR15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1100\/tsw.2001.58","volume":"1","author":"AB Mitnitski","year":"2001","unstructured":"Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal. 2001;1:323\u201336.","journal-title":"ScientificWorldJournal"},{"issue":"5","key":"777_CR16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489\u201395.","journal-title":"CMAJ"},{"issue":"3","key":"777_CR17","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146\u201356.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"777_CR18","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/ageing\/afl041","volume":"35","author":"DB Rolfson","year":"2006","unstructured":"Rolfson DB, et al. Validity and reliability of the Edmonton Frail Scale. Age Ageing. 2006;35(5):526\u20139.","journal-title":"Age Ageing"},{"issue":"5","key":"777_CR19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/ageing\/26.5.367","volume":"26","author":"DH Thom","year":"1997","unstructured":"Thom DH, Haan MN, Van Den Eeden SK. Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality. Age Ageing. 1997;26(5):367\u201374.","journal-title":"Age Ageing"},{"key":"777_CR20","doi-asserted-by":"crossref","unstructured":"Wang CJ, et al. Urinary incontinence and its association with frailty among men aged 80 years and older in Taiwan: a cross-sectional study. Rejuvenation Res. 2016.","DOI":"10.1089\/rej.2016.1855"},{"issue":"1","key":"777_CR21","doi-asserted-by":"crossref","first-page":"M19","DOI":"10.1093\/gerona\/56.1.M19","volume":"56","author":"TP Miles","year":"2001","unstructured":"Miles TP, et al. New-onset incontinence and markers of frailty: data from the Hispanic Established Populations for Epidemiologic Studies of the Elderly. J Gerontol A Biol Sci Med Sci. 2001;56(1):M19\u201324.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"777_CR22","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1532-5415.2004.52207.x","volume":"52","author":"JM Holroyd-Leduc","year":"2004","unstructured":"Holroyd-Leduc JM, Mehta KM, Covinsky KE. Urinary incontinence and its association with death, nursing home admission, and functional decline. J Am Geriatr Soc. 2004;52(5):712\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"777_CR23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1590\/S0080-62342011000300018","volume":"45","author":"VA Silva","year":"2011","unstructured":"Silva VA, Souza KL, D\u2019Elboux MJ. Urinary incontinence and the criteria of frailness among the elderly outpatients. Revista da Escola de Enfermagem da. 2011;45(3):672\u20138.","journal-title":"Revista da Escola de Enfermagem da"},{"issue":"1","key":"777_CR24","first-page":"9","volume":"38","author":"VE Closs","year":"2016","unstructured":"Closs VE, Ziegelmann P, Gomes I, Schwanke CHA. Frailty and Geriatric Syndromes in elderly assisted in primary health care. Acta Sci. 2016;38(1):9\u201318.","journal-title":"Acta Sci"},{"issue":"3","key":"777_CR25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/jech.37.3.176","volume":"37","author":"LJ Donaldson","year":"1983","unstructured":"Donaldson LJ, Jagger C. Survival and functional capacity: three year follow up of an elderly population in hospitals and homes. J Epidemiol Community Health. 1983;37(3):176\u20139.","journal-title":"J Epidemiol Community Health"},{"issue":"3","key":"777_CR26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1532-5415.1994.tb01749.x","volume":"42","author":"AR Herzog","year":"1994","unstructured":"Herzog AR, et al. Urinary incontinence as a risk factor for mortality. J Am Geriatr Soc. 1994;42(3):264\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"777_CR27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/089826430001200102","volume":"12","author":"TM Johnson 2nd","year":"2000","unstructured":"Johnson TM 2nd, et al. Urinary incontinence and risk of death among community-living elderly people: results from the National Survey on Self-Care and Aging. J Aging Health. 2000;12(1):25\u201346.","journal-title":"J Aging Health"},{"issue":"9","key":"777_CR28","first-page":"533","volume":"30","author":"BJ Zarowitz","year":"2015","unstructured":"Zarowitz BJ, et al. Clinical burden and nonpharmacologic management of nursing facility residents with overactive bladder and\/or urinary incontinence. Consult Pharm J Am Soc Consult Pharm. 2015;30(9):533\u201342.","journal-title":"Consult Pharm J Am Soc Consult Pharm"},{"issue":"8","key":"777_CR29","doi-asserted-by":"crossref","first-page":"e13207","DOI":"10.1111\/ijcp.13207","volume":"73","author":"CC Chuang","year":"2019","unstructured":"Chuang CC, et al. Health and functional status, health events, use of healthcare services and costs associated with overactive bladder among the medically complex vulnerable elderly in the US. Int J Clin Pract. 2019;73(8):e13207.","journal-title":"Int J Clin Pract"},{"key":"777_CR30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.urology.2017.03.058","volume":"106","author":"AM Suskind","year":"2017","unstructured":"Suskind AM, et al. Overactive bladder is strongly associated with frailty in older individuals. Urology. 2017;106:26\u201331.","journal-title":"Urology"},{"key":"777_CR31","unstructured":"Matta R, et al. Is there an association between urinary incontinence and mortality? A retrospective cohort study. J Urol. 2019;101097ju0000000000000574."},{"issue":"11","key":"777_CR32","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1111\/j.1365-2648.2010.05422.x","volume":"66","author":"EA Elstad","year":"2010","unstructured":"Elstad EA, et al. Beyond incontinence: the stigma of other urinary symptoms. J Adv Nurs. 2010;66(11):2460\u201370.","journal-title":"J Adv Nurs"},{"issue":"2","key":"777_CR33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1525\/maq.1995.9.2.02a00050","volume":"9","author":"LS Mitteness","year":"1995","unstructured":"Mitteness LS, Barker JC. Stigmatizing a \u201cnormal\u201d condition: urinary incontinence in late life. Med Anthropol Q. 1995;9(2):188\u2013210.","journal-title":"Med Anthropol Q"},{"issue":"3","key":"777_CR34","first-page":"39","volume":"17","author":"J Tumolo","year":"2009","unstructured":"Tumolo J. No fear here. Overcoming the stigma of urinary incontinence. Adv Nurse Pract. 2009;17(3):39\u201341.","journal-title":"Adv Nurse Pract"},{"issue":"4","key":"777_CR35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.maturitas.2014.01.009","volume":"77","author":"C Wang","year":"2014","unstructured":"Wang C, et al. Disease stigma and intentions to seek care for stress urinary incontinence among community-dwelling women. Maturitas. 2014;77(4):351\u20135.","journal-title":"Maturitas"},{"issue":"3","key":"777_CR36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/ageing\/afx188","volume":"47","author":"CR Gale","year":"2018","unstructured":"Gale CR, Westbury L, Cooper C. Social isolation and loneliness as risk factors for the progression of frailty: the English Longitudinal Study of Ageing. Age Ageing. 2018;47(3):392\u20137.","journal-title":"Age Ageing"},{"issue":"5","key":"777_CR37","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ajog.2009.05.047","volume":"201","author":"JL Melville","year":"2009","unstructured":"Melville JL, et al. Major depression and urinary incontinence in women: temporal associations in an epidemiologic sample. Am J Obstet Gynecol. 2009;201(5):490.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"777_CR38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1067\/mob.2002.124839","volume":"187","author":"JL Melville","year":"2002","unstructured":"Melville JL, et al. Prevalence of comorbid psychiatric illness and its impact on symptom perception, quality of life, and functional status in women with urinary incontinence. Am J Obstet Gynecol. 2002;187(1):80\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"Pt 3","key":"777_CR39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1348\/135910705X60742","volume":"11","author":"S Perry","year":"2006","unstructured":"Perry S, McGrother CW, Turner K. An investigation of the relationship between anxiety and depression and urge incontinence in women: development of a psychological model. Br J Health Psychol. 2006;11(Pt 3):463\u201382.","journal-title":"Br J Health Psychol"},{"issue":"1","key":"777_CR40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eururo.2011.07.049","volume":"61","author":"KS Coyne","year":"2012","unstructured":"Coyne KS, et al. Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States. Eur Urol. 2012;61(1):88\u201395.","journal-title":"Eur Urol"},{"issue":"3","key":"777_CR41","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1442-2042.2010.02696.x","volume":"18","author":"Y Ikeda","year":"2011","unstructured":"Ikeda Y, et al. Risk factors for overactive bladder in the elderly population: a community-based study with face-to-face interview. Int J Urol. 2011;18(3):212\u20138.","journal-title":"Int J Urol"},{"issue":"1","key":"777_CR42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/nau.20798","volume":"29","author":"BT Haylen","year":"2010","unstructured":"Haylen BT, et al. An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4\u201320.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"777_CR43","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1464-410X.2005.05279.x","volume":"95","author":"CR Chapple","year":"2005","unstructured":"Chapple CR, Wein AJ. The urgency of the problem and the problem of urgency in the overactive bladder. BJU Int. 2005;95(3):274\u20135.","journal-title":"BJU Int"},{"issue":"6","key":"777_CR44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrn2401","volume":"9","author":"CJ Fowler","year":"2008","unstructured":"Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):453\u201366.","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"777_CR45","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/S0022-5347(05)64290-5","volume":"168","author":"S Matsuura","year":"2002","unstructured":"Matsuura S, et al. Human brain region response to distention or cold stimulation of the bladder: a positron emission tomography study. J Urol. 2002;168(5):2035\u20139.","journal-title":"J Urol"},{"issue":"1","key":"777_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2007.04.061","volume":"37","author":"D Griffiths","year":"2007","unstructured":"Griffiths D, et al. Cerebral control of the bladder in normal and urge-incontinent women. Neuroimage. 2007;37(1):1\u20137.","journal-title":"Neuroimage"},{"issue":"4","key":"777_CR47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF00839137","volume":"239","author":"DA Bennett","year":"1992","unstructured":"Bennett DA, et al. Clinical correlates of high signal lesions on magnetic-resonance-imaging in Alzheimers-disease. J Neurol. 1992;239(4):186\u201390.","journal-title":"J Neurol"},{"issue":"7","key":"777_CR48","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1212\/WNL.44.7.1246","volume":"44","author":"MM Breteler","year":"1994","unstructured":"Breteler MM, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 1994;44(7):1246\u201352.","journal-title":"Neurology"},{"issue":"7","key":"777_CR49","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/01.STR.26.7.1171","volume":"26","author":"A Ylikoski","year":"1995","unstructured":"Ylikoski A, et al. White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55\u201385\u00a0years living at home. Stroke. 1995;26(7):1171\u20137.","journal-title":"Stroke"},{"issue":"8","key":"777_CR50","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/gerona\/59.8.M818","volume":"59","author":"HK Kuo","year":"2004","unstructured":"Kuo HK, Lipsitz LA. Cerebral white matter changes and geriatric syndromes: is there a link? J Gerontol A Biol Sci Med Sci. 2004;59(8):818\u201326.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"777_CR51","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1532-5415.2009.02699.x","volume":"58","author":"DB Wakefield","year":"2010","unstructured":"Wakefield DB, et al. White matter hyperintensities predict functional decline in voiding, mobility, and cognition in older adults. J Am Geriatr Soc. 2010;58(2):275\u201381.","journal-title":"J Am Geriatr Soc"},{"key":"777_CR52","doi-asserted-by":"crossref","unstructured":"Enzinger C, et al. White matter hyperintensities alter the functional organization of the motor system with ageing\u2014First evidence from FMRI. In: 19th European Stroke Conference Barcelona Spain, 2010. vol. 29: p. 79.","DOI":"10.1159\/000315008"},{"issue":"3","key":"777_CR53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","volume":"11","author":"ND Prins","year":"2015","unstructured":"Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol. 2015;11(3):157\u201365.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"777_CR54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10286-013-0187-9","volume":"23","author":"H Haruta","year":"2013","unstructured":"Haruta H, et al. Inhibitory control task is decreased in vascular incontinence patients. Clin Auton Res. 2013;23(2):85\u20139.","journal-title":"Clin Auton Res"},{"key":"777_CR55","unstructured":"Gary B, et al. Severity and impact of urge urinary incontinence is associated with white matter hyperintensity burden in functional community-dwelling older women. In: 2013 Annual Scientific Meeting of the American Geriatrics Society Grapevine, TX United States, 2013. 61: p. S209."},{"issue":"1","key":"777_CR56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/iju.12288","volume":"21","author":"R Sakakibara","year":"2014","unstructured":"Sakakibara R, et al. Is overactive bladder a brain disease? The pathophysiological role of cerebral white matter in the elderly. Int J Urol. 2014;21(1):33\u20138.","journal-title":"Int J Urol"},{"issue":"5","key":"777_CR57","first-page":"321","volume":"19","author":"JA Avila-Funes","year":"2006","unstructured":"Avila-Funes JA, Garant MP, Aguilar-Navarro S. Relationship between determining factors for depressive symptoms and for dietary habits in older adults in Mexico. Rev Panam Salud Publica. 2006;19(5):321\u201330.","journal-title":"Rev Panam Salud Publica"},{"key":"777_CR58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neurobiolaging.2016.04.025","volume":"44","author":"CP Chung","year":"2016","unstructured":"Chung CP, et al. Cerebral microbleeds are associated with physical frailty: a community-based study. Neurobiol Aging. 2016;44:143\u201350.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"777_CR59","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/ggi.12708","volume":"17","author":"OH Del Brutto","year":"2017","unstructured":"Del Brutto OH, et al. Neuroimaging signatures of frailty: A population-based study in community-dwelling older adults (the Atahualpa Project). Geriatr Gerontol Int. 2017;17(2):270\u20136.","journal-title":"Geriatr Gerontol Int"},{"key":"777_CR60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neurobiolaging.2018.06.032","volume":"70","author":"IMJ Kant","year":"2018","unstructured":"Kant IMJ, et al. The association between brain volume, cortical brain infarcts, and physical frailty. Neurobiol Aging. 2018;70:247\u201353.","journal-title":"Neurobiol Aging"},{"key":"777_CR61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exger.2019.01.007","volume":"118","author":"M Maltais","year":"2019","unstructured":"Maltais M, et al. Prospective association of white matter hyperintensity volume and frailty in older adults. Exp Gerontol. 2019;118:51\u20134.","journal-title":"Exp Gerontol"},{"issue":"2","key":"777_CR62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/gerona\/glx145","volume":"73","author":"TP Siejka","year":"2018","unstructured":"Siejka TP, et al. Frailty and cerebral small vessel disease: a cross-sectional analysis of the tasmanian study of cognition and gait (TASCOG). J Gerontol A Biol Sci Med Sci. 2018;73(2):255\u201360.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"777_CR63","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ana.21826","volume":"67","author":"V Srikanth","year":"2010","unstructured":"Srikanth V, et al. The location of white matter lesions and gait\u2013a voxel-based study. Ann Neurol. 2010;67(2):265\u20139.","journal-title":"Ann Neurol"},{"issue":"15","key":"777_CR64","doi-asserted-by":"crossref","first-page":"e1291","DOI":"10.1212\/WNL.0000000000005289","volume":"90","author":"SY Moon","year":"2018","unstructured":"Moon SY, et al. Prospective associations between white matter hyperintensities and lower extremity function. Neurology. 2018;90(15):e1291\u20137.","journal-title":"Neurology"},{"issue":"7","key":"777_CR65","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1161\/STROKEAHA.110.610360","volume":"42","author":"JJ Zheng","year":"2011","unstructured":"Zheng JJ, et al. Impact of white matter lesions on physical functioning and fall risk in older people: a systematic review. Stroke. 2011;42(7):2086\u201390.","journal-title":"Stroke"},{"issue":"2","key":"777_CR66","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.4081\/ni.2012.e13","volume":"4","author":"R Sakakibara","year":"2012","unstructured":"Sakakibara R, et al. Vascular incontinence: incontinence in the elderly due to ischemic white matter changes. Neurol Int. 2012;4(2):e13.","journal-title":"Neurol Int"},{"key":"777_CR67","doi-asserted-by":"crossref","unstructured":"Wagg A, et al. Urinary incontinence in frail elderly persons: Report from the 5th International Consultation on Incontinence. Neurourology and Urodynamics, 2014.","DOI":"10.1002\/nau.22602"},{"issue":"1","key":"777_CR68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1464-410X.2003.04268.x","volume":"92","author":"CT Brown","year":"2003","unstructured":"Brown CT, et al. Lifestyle and behavioural interventions for men on watchful waiting with uncomplicated lower urinary tract symptoms: a national multidisciplinary survey. BJU Int. 2003;92(1):53\u20137.","journal-title":"BJU Int"},{"issue":"6","key":"777_CR69","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7326\/0003-4819-148-6-200803180-00210","volume":"148","author":"CS Landefeld","year":"2008","unstructured":"Landefeld CS, et al. National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults. Ann Intern Med. 2008;148(6):449\u201358.","journal-title":"Ann Intern Med"},{"issue":"8","key":"777_CR70","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1742-1241.2009.02078.x","volume":"63","author":"JF Wyman","year":"2009","unstructured":"Wyman JF, Burgio KL, Newman DK. Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence. Int J Clin Pract. 2009;63(8):1177\u201391.","journal-title":"Int J Clin Pract"},{"issue":"4","key":"777_CR71","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/nau.20413","volume":"26","author":"JE Kincade","year":"2007","unstructured":"Kincade JE, et al. Randomized clinical trial of efficacy of self-monitoring techniques to treat urinary incontinence in women. Neurourol Urodyn. 2007;26(4):507\u201311.","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"777_CR72","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3928\/00989134-20160201-01","volume":"42","author":"J McCrow","year":"2016","unstructured":"McCrow J, et al. Associations between dehydration, cognitive impairment, and frailty in older hospitalized patients: an exploratory study. J Gerontol Nurs. 2016;42(5):19\u201327.","journal-title":"J Gerontol Nurs"},{"issue":"1","key":"777_CR73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1891\/1541-6577.25.1.11","volume":"25","author":"PM Gaspar","year":"2011","unstructured":"Gaspar PM. Comparison of four standards for determining adequate water intake of nursing home residents. Res Theory Nurs Pract. 2011;25(1):11\u201322.","journal-title":"Res Theory Nurs Pract"},{"issue":"3","key":"777_CR74","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.apnr.2009.07.001","volume":"24","author":"P Voyer","year":"2011","unstructured":"Voyer P, et al. Precipitating factors associated with delirium among long-term care residents with dementia. Appl Nurs Res. 2011;24(3):171\u20138.","journal-title":"Appl Nurs Res"},{"issue":"2","key":"777_CR75","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000348344","volume":"91","author":"A Rose","year":"2013","unstructured":"Rose A, et al. Severity of urinary incontinence of nursing home residents correlates with malnutrition, dementia and loss of mobility. Urol Int. 2013;91(2):165\u20139.","journal-title":"Urol Int"},{"issue":"29","key":"777_CR76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3310\/hta12290","volume":"12","author":"M Fader","year":"2008","unstructured":"Fader M, et al. Absorbent products for urinary\/faecal incontinence: a comparative evaluation of key product designs. Health Technol Assess. 2008;12(29):9\u2013185.","journal-title":"Health Technol Assess"},{"key":"777_CR77","doi-asserted-by":"crossref","unstructured":"Fader M, Cottenden AM, Getliffe K. Absorbent products for light urinary incontinence in women. Cochrane Database Syst Rev. 2007(2): p. CD001406.","DOI":"10.1002\/14651858.CD001406.pub2"},{"key":"777_CR78","doi-asserted-by":"crossref","unstructured":"Fader M, Cottenden AM, Getliffe K. Absorbent products for moderate-heavy urinary and\/or faecal incontinence in women and men. Cochrane Database Syst Rev. 2008(4): p. CD007408.","DOI":"10.1002\/14651858.CD007408"},{"issue":"5","key":"777_CR79","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1464-410X.2007.07205.x","volume":"100","author":"P Abrams","year":"2007","unstructured":"Abrams P, Andersson KE. Muscarinic receptor antagonists for overactive bladder. BJU Int. 2007;100(5):987\u20131006.","journal-title":"BJU Int"},{"issue":"4","key":"777_CR80","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.juro.2009.06.051","volume":"182","author":"E Martin-Merino","year":"2009","unstructured":"Martin-Merino E, et al. Do oral antimuscarinic drugs carry an increased risk of acute urinary retention? J Urol. 2009;182(4):1442\u20138.","journal-title":"J Urol"},{"issue":"9","key":"777_CR81","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jamda.2010.05.003","volume":"12","author":"TE Lackner","year":"2011","unstructured":"Lackner TE, et al. Efficacy of oral extended-release oxybutynin in cognitively impaired older nursing home residents with urge urinary incontinence: a randomized placebo-controlled trial. J Am Med Dir Assoc. 2011;12(9):639\u201347.","journal-title":"J Am Med Dir Assoc"},{"issue":"9","key":"777_CR82","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/ijcp.12447","volume":"68","author":"W Gibson","year":"2014","unstructured":"Gibson W, et al. Are we short changing frail older people when it comes to the pharmacological treatment of urgency urinary incontinence? Int J Clin Pract. 2014;68(9):1165\u201373.","journal-title":"Int J Clin Pract"},{"key":"777_CR83","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.5489\/cuaj.11188","volume":"5","author":"A Wagg","year":"2011","unstructured":"Wagg A. Treating overactive bladder in the elderly. Can Urol Assoc J. 2011;5:S149\u201351.","journal-title":"Can Urol Assoc J"},{"key":"777_CR84","doi-asserted-by":"crossref","unstructured":"Wagg A, Dale M, Compion G, Stow B, Tretter R. Solifenacin and cognitive impairment in elderly people with mild cognitive impairment: the SENIOR study. 2012.","DOI":"10.1016\/S1569-9056(12)60686-1"},{"issue":"6","key":"777_CR85","first-page":"800","volume":"32","author":"M Oelke","year":"2013","unstructured":"Oelke M, Murgas S, Schneider T, He\u00dfd\u00f6rfer E. Influence of propiverine ER 30 mg once daily on cognitive function in elderly female and male patients with overactive bladder: a non-interventional study to assess real life data. Neurourol Urodyn. 2013;32(6):800\u20132.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"777_CR86","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10286-013-0200-3","volume":"23","author":"R Sakakibara","year":"2013","unstructured":"Sakakibara R, et al. Imidafenacin on bladder and cognitive function in neurologic OAB patients. Clin Auton Res. 2013;23(4):189\u201395.","journal-title":"Clin Auton Res"},{"issue":"1","key":"777_CR87","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000350029","volume":"3","author":"JW Park","year":"2013","unstructured":"Park JW. The effect of solifenacin on cognitive function following stroke. Dementia Geriatr Cogn Disord Extra. 2013;3(1):143\u20137.","journal-title":"Dementia Geriatr Cogn Disord Extra"},{"key":"777_CR88","doi-asserted-by":"crossref","unstructured":"DuBeau CE, Kraus SR, Griebling TL, Newman DK, Wyman JF, Johnson TM 2nd, Ouslander JG, Sun F, Gong J, Bavendam T. Effect of fesoterodine in vulnerable elderly subjects with urgency incontinence: a double-blind, placebo-controlled trial. J Urol. 2013. JURO 10640.","DOI":"10.1016\/j.juro.2013.08.027"},{"issue":"12","key":"777_CR89","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1046\/j.1532-5415.2001.49281.x","volume":"49","author":"D Saliba","year":"2001","unstructured":"Saliba D, et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49(12):1691\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"777_CR90","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/nau.22603","volume":"34","author":"A Wagg","year":"2015","unstructured":"Wagg A, et al. Factors associated with dose escalation of fesoterodine for treatment of overactive bladder in people\u2009>\u200965\u00a0years of age: a post hoc analysis of data from the SOFIA study. Neurourol Urodyn. 2015;34(5):438\u201343.","journal-title":"Neurourol Urodyn"},{"key":"777_CR91","volume-title":"Clinical guidelines, in urinary incontinence and pelvic organ prolapse in women: management","author":"National Institute for Health and Care Excellence","year":"2019","unstructured":"National Institute for Health and Care Excellence. Clinical guidelines, in urinary incontinence and pelvic organ prolapse in women: management. London: NICE; 2019."},{"issue":"4","key":"777_CR92","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.eururo.2017.12.031","volume":"73","author":"AK Nambiar","year":"2018","unstructured":"Nambiar AK, et al. EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol. 2018;73(4):596\u2013609.","journal-title":"Eur Urol"},{"issue":"9","key":"777_CR93","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40266-018-0575-x","volume":"35","author":"HJ Woodford","year":"2018","unstructured":"Woodford HJ. Anticholinergic drugs for overactive bladder in frail older patients: the case against. Drugs Aging. 2018;35(9):773\u20136.","journal-title":"Drugs Aging"},{"issue":"1","key":"777_CR94","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/nau.23309","volume":"37","author":"KD Kistler","year":"2018","unstructured":"Kistler KD, et al. Systematic literature review of clinical trials evaluating pharmacotherapy for overactive bladder in elderly patients: an assessment of trial quality. Neurourol Urodyn. 2018;37(1):54\u201366.","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"777_CR95","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/nau.24093","volume":"38","author":"AM Suskind","year":"2019","unstructured":"Suskind AM, et al. The impact of frailty on treatment for overactive bladder in older adults. Neurourol Urodyn. 2019;38(7):1915\u201323.","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"777_CR96","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1532-5415.2007.01143.x","volume":"55","author":"JM Starr","year":"2007","unstructured":"Starr JM. Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer\u2019s disease. J Am Geriatr Soc. 2007;55(5):800\u20131.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"777_CR97","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archinte.165.7.808","volume":"165","author":"S Gill","year":"2005","unstructured":"Gill S, Mamdani M, Naglie G, Streiner DL, Bronskill SE, Kopp A, Shulman KI, Lee PE, Rochon PA. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med. 2005;165(7):808\u201313.","journal-title":"Arch Intern Med"},{"issue":"8","key":"777_CR98","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s12603-009-0196-5","volume":"13","author":"AT Isik","year":"2009","unstructured":"Isik AT, et al. Trospium and cognition in patients with late onset Alzheimer disease. J Nutr Health Aging. 2009;13(8):672\u20136.","journal-title":"J Nutr Health Aging"},{"issue":"4","key":"777_CR99","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1185\/03007995.2016.1149806","volume":"32","author":"A Wagg","year":"2016","unstructured":"Wagg A, et al. Oral pharmacotherapy for overactive bladder in older patients: mirabegron as a potential alternative to antimuscarinics. Curr Med Res Opin. 2016;32(4):621\u201338.","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"777_CR100","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.clinthera.2012.09.010","volume":"34","author":"W Krauwinkel","year":"2012","unstructured":"Krauwinkel W, et al. Pharmacokinetic properties of mirabegron, a beta3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women. Clin Ther. 2012;34(10):2144\u201360.","journal-title":"Clin Ther"},{"issue":"1","key":"777_CR101","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40261-012-0031-3","volume":"33","author":"J Dickinson","year":"2013","unstructured":"Dickinson J, et al. Effect of renal or hepatic impairment on the pharmacokinetics of mirabegron. Clin Drug Investig. 2013;33(1):11\u201323.","journal-title":"Clin Drug Investig"},{"issue":"1","key":"777_CR102","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s13318-013-0133-1","volume":"39","author":"W Krauwinkel","year":"2014","unstructured":"Krauwinkel W, et al. The effect of mirabegron, a potent and selective beta3-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol. Eur J Drug Metab Pharmacokinet. 2014;39(1):43\u201352.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"2","key":"777_CR103","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.eururo.2015.09.007","volume":"69","author":"GM Rosa","year":"2016","unstructured":"Rosa GM, et al. Cardiovascular safety of beta3-adrenoceptor agonists for the treatment of patients with overactive bladder syndrome. Eur Urol. 2016;69(2):311\u201323.","journal-title":"Eur Urol"},{"key":"777_CR104","doi-asserted-by":"crossref","unstructured":"Wagg A, et al. Efficacy, safety, and tolerability of mirabegron in patients aged\u2009\u2265\u00a065\u00a0year with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR). Eur Urol. 2019.","DOI":"10.1016\/j.eururo.2019.10.002"},{"issue":"1","key":"777_CR105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12877-020-1474-7","volume":"20","author":"TL Griebling","year":"2020","unstructured":"Griebling TL, et al. Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR). BMC Geriatr. 2020;20(1):109.","journal-title":"BMC Geriatr"},{"issue":"4","key":"777_CR106","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/toxins8040091","volume":"8","author":"CH Liao","year":"2016","unstructured":"Liao CH, Wang CC, Jiang YH. Intravesical OnabotulinumtoxinA injection for overactive bladder patients with frailty, medical comorbidities or prior lower urinary tract surgery. Toxins (Basel). 2016;8(4):91.","journal-title":"Toxins (Basel)"},{"issue":"2","key":"777_CR107","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s41999-017-0013-3","volume":"9","author":"C Hentzen","year":"2018","unstructured":"Hentzen C, et al. Efficacy of posterior tibial nerve stimulation (PTNS) on overactive bladder in older adults. Eur Geriatr Med. 2018;9(2):249\u201353.","journal-title":"Eur Geriatr Med"},{"issue":"3","key":"777_CR108","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.eururo.2017.11.002","volume":"73","author":"M Tutolo","year":"2018","unstructured":"Tutolo M, et al. Efficacy and safety of sacral and percutaneous tibial neuromodulation in non-neurogenic lower urinary tract dysfunction and chronic pelvic pain: a systematic review of the literature. Eur Urol. 2018;73(3):406\u201318.","journal-title":"Eur Urol"},{"issue":"Suppl 2","key":"777_CR109","doi-asserted-by":"crossref","first-page":"S485","DOI":"10.1007\/s00192-010-1278-y","volume":"21","author":"TL Griebling","year":"2010","unstructured":"Griebling TL. Sacral nerve stimulation in the elderly. Int Urogynecol J. 2010;21(Suppl 2):S485\u20139.","journal-title":"Int Urogynecol J"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00777-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-020-00777-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00777-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T19:32:03Z","timestamp":1624044723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-020-00777-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":109,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1007\/s40266-020-00777-8","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]},"assertion":[{"value":"19 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Dr. Shaw has no conflicts of interest that are directly relevant to the content of this article. Dr. Wagg has received funding for consultancy, speaker fees, and research from Astellas Pharma, Pfizer Inc, and Essity Health and Hygiene AB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}